These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19047137)

  • 1. The ARF tumor suppressor can promote the progression of some tumors.
    Humbey O; Pimkina J; Zilfou JT; Jarnik M; Dominguez-Brauer C; Burgess DJ; Eischen CM; Murphy ME
    Cancer Res; 2008 Dec; 68(23):9608-13. PubMed ID: 19047137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
    Bertwistle D; Sherr CJ
    Blood; 2007 Jan; 109(2):792-4. PubMed ID: 16968893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
    Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
    Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
    Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
    Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
    Pinyol M; Hernández L; Martínez A; Cobo F; Hernández S; Beà S; López-Guillermo A; Nayach I; Palacín A; Nadal A; Fernández PL; Montserrat E; Cardesa A; Campo E
    Am J Pathol; 2000 Jun; 156(6):1987-96. PubMed ID: 10854221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small mitochondrial Arf (smArf) protein corrects p53-independent developmental defects of
    van Oosterwijk JG; Li C; Yang X; Opferman JT; Sherr CJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7420-7425. PubMed ID: 28652370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
    Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
    Kelly-Spratt KS; Gurley KE; Yasui Y; Kemp CJ
    PLoS Biol; 2004 Aug; 2(8):E242. PubMed ID: 15314658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved domain in exon 2 coding for the human and murine ARF tumor suppressor protein is required for autophagy induction.
    Budina-Kolomets A; Hontz RD; Pimkina J; Murphy ME
    Autophagy; 2013 Oct; 9(10):1553-65. PubMed ID: 23939042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse.
    Khoo CM; Carrasco DR; Bosenberg MW; Paik JH; Depinho RA
    Proc Natl Acad Sci U S A; 2007 Mar; 104(10):3931-6. PubMed ID: 17360455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways.
    Sánchez-Aguilera A; Sánchez-Beato M; García JF; Prieto I; Pollan M; Piris MA
    Blood; 2002 Feb; 99(4):1411-8. PubMed ID: 11830494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
    Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
    Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of p53 function at late stages of tumorigenesis confers ARF-dependent vulnerability to p53 reactivation therapy.
    Klimovich B; Mutlu S; Schneikert J; Elmshäuser S; Klimovich M; Nist A; Mernberger M; Timofeev O; Stiewe T
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22288-22293. PubMed ID: 31611375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain of function in the mouse model of a recurrent mutation p53
    Zhao L; Wang B; Zhao X; Wu X; Zhang Q; Wei C; Shi M; Li Y; Tang W; Zhang J; Yang J; Singh SK; Jia S; Luo Y
    Mol Carcinog; 2018 Feb; 57(2):147-158. PubMed ID: 28949402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function.
    Pimkina J; Murphy ME
    Cancer Biol Ther; 2011 Sep; 12(6):503-9. PubMed ID: 21738007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing tumor-suppressor functions of Arf and p53 in murine basal cell carcinoma initiation and progression.
    Wang GY; Wood CN; Dolorito JA; Libove E; Epstein EH
    Oncogene; 2017 Jun; 36(26):3772-3780. PubMed ID: 28263978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the p16(INK4) locus in human malignant mesothelial tumors.
    Hirao T; Bueno R; Chen CJ; Gordon GJ; Heilig E; Kelsey KT
    Carcinogenesis; 2002 Jul; 23(7):1127-30. PubMed ID: 12117769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.